Pazopanib/Pazopanib Price List

Pazopanib/Pazopanib (Pazopanib) is a targeted therapy drug called a tyrosine kinase inhibitor (TKI). It is a multi-kinase inhibitor against vascular endothelial growth factor receptor-1, -2 and -3. These are also known as cancer growth inhibitors and are mainly used to treat advanced renal cell carcinoma and soft tissue sarcoma.

Kinases are important proteins in the body. They control how cells grow and divide. Pazopanib blocks proteins (kinases) that cancer cells send to signal them to grow. Blocking the signal causes cancer cells to die. Pazopanib also prevents cancer cells from developing new blood vessels. This reduces their supply of oxygen and nutrients, so tumors shrink or stop growing. This is called anti-angiogenic therapy.

Pazopanib is a tablet that patients can take at home, once a day at the same time. Take it at least 2 hours after a meal or 1 hour before a meal because food can affect the absorption of pazopanib. Pazopanib is usually continued as long as it is effective for patients. Do not stop taking pazopanib without talking to your doctor.

The original drug of pazopanib tablets has been launched in the domestic market and has successfully been included in the list of drugs reimbursed by medical insurance, but the reimbursement targets are only limited to patients who meet its indications. Common drug specifications on the market include 200mg 30 tablets and 400mg 30 tablets, with prices around RMB 3,000 per box. In overseas markets, the price of original drugs may fluctuate around 2,000 yuan per box, depending on changes in exchange rates. At the same time, generic drugs of pazopanib are also available overseas, and their ingredients are roughly the same as the original drug. For example, the price of drugs produced by Bangladesh pharmaceutical factories may only be around 500 yuan per box, but this price may also change due to exchange rates.